Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs Google Inc (GOOG) Price & Performance

ClearPoint Neuro IncTrade
Google IncTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs Google Inc — how do they compare? ClearPoint Neuro Inc trades at $14.56 (market cap $454.21M), while Google Inc trades at $341.59 (market cap $4.20T). The key difference: Google Inc is far larger — about 9246.8× ClearPoint Neuro Inc's market cap, and Google Inc pays a 0.26% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CLPTGOOG
Market Cap
$454.21M$4.20T
Sector
HealthTechnology
52-Week High
$29.60$399.06
52-Week Low
$8.66$200.19
Enterprise Value
$488.79M$4.09T
Volume
1,511,127
Dividend Yield
0.26%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ClearPoint Neuro Inc

ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.

The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.

Google Inc

Alphabet (GOOG) trades at $355.84, up 0.67% on the day, with a bullish technical signal from moving averages and strong quarterly earnings beats. The company reported robust revenue growth to $402.84 billion in 2025, with net income surging to $132.17 billion, and announced a new AI leadership structure to accelerate Gemini development amid rising user adoption.

Outlook remains positive with an 86.84% analyst buy rating and a $431.67 consensus price target, though risks include high capital expenditure for AI infrastructure and regulatory scrutiny. The stock offers growth potential from AI monetization but faces volatility from tech sector pressures and antitrust investigations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG